We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

By LabMedica International staff writers
Posted on 30 Oct 2026

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. More...

People with sickle cell trait or beta-thalassemia trait often have few or no symptoms but can pass the genetic change to their children. Carrier identification has varied over time, leaving some adults born before comparable newborn screening was available unaware of their status. New findings suggest that genetic testing may help identify these carriers earlier.

Mayo Clinic (Rochester, MN, USA) researchers evaluated genetic testing for identifying carriers of sickle cell and beta-thalassemia traits. Both are associated with hemoglobinopathies, inherited disorders affecting hemoglobin, the oxygen-carrying protein in red blood cells. In sickle cell anemia, abnormal hemoglobin can make red blood cells rigid, sticky, and misshapen, whereas beta-thalassemia reduces hemoglobin production and can lead to anemia.

The study drew on Tapestry, an initiative that enrolled more than 98,000 participants across Mayo Clinic between July 2020 and May 2024 and generated whole-exome sequencing data to support clinical care, research discovery, and genomic education. Using data from nearly 50,000 participants, researchers searched for variants associated with sickle cell trait and beta-thalassemia trait, then compared their findings with diagnosis codes in electronic health records.

Genetic testing identified 116 participants with sickle cell trait, of whom only 19 had a corresponding diagnosis code. Similarly, 98 participants carried beta-thalassemia trait, but only 47 had a matching code. The team also found instances in which existing diagnosis codes did not align with genetic findings. The authors noted that further research is needed to understand these discrepancies, including the roles of historical screening, classification, and documentation practices.

Published in Mayo Clinic Proceedings on October 27, 2026, the findings highlight opportunities for clearer guidance on identifying hemoglobinopathy carriers and determining when genetic testing and counseling may be appropriate. This emphasis on earlier risk identification also aligns with Mayo Clinic’s Precure Research initiative, which develops tools and approaches to recognize disease-related risk before symptoms emerge or conditions become more difficult to treat.

“If we can identify carrier status earlier, we have more opportunities for reproductive counseling, appropriate preventive care and helping patients understand what these findings may mean for their families,” said Nathaniel Miller, M.D., a Mayo Clinic family medicine physician and first author of the study.

“From a primary care and population health perspective, the goal is to identify carrier status early, ideally before pregnancy, because many people don't know they are carriers. That creates an important opportunity for preconception counseling and informed family planning,” said Isa Houwink, M.D., Ph.D., a Mayo Clinic family medicine physician and senior author of the study.

Related Links
Mayo Clinic 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The MIRAM GAGome Kit quantifies urine CS disaccharides by UHPLC-MS/MS, supporting exploratory and translational research across disease areas. (Photo courtesy of Elypta)

Study Finds Urine Biomarker Score Improves Five-Year Cancer Risk Prediction

Cancer risk stratification in healthy adults often relies on established factors such as age and smoking history. However, several cancers highlighted in the study, including pancreatic, kidney, and brain... Read more

Molecular Diagnostics

view channel
Image: A blood test measuring circulating tumor DNA may help identify men with hormone-resistant oligoprogressive prostate cancer most likely to benefit from stereotactic body radiotherapy (Image Credit: Adobe Stock)

Blood Test Identifies Candidates for Targeted Radiotherapy in Advanced Prostate Cancer

Advanced prostate cancer can progress despite hormone-based treatment, with imaging sometimes revealing only limited areas of active disease. For men with hormone-resistant oligoprogressive prostate cancer,... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.